Moreover, the presence of CXCR3+ TH17 cells correlated with increased disease severity in humans, suggesting that this is an evolutionarily conserved aspect of NAFLD and NASH. This evidence concerns the gene CXCR3 and metabolic dysfunction-associated steatotic liver disease.